Home > Journals > Journal of Neurosurgical Sciences > Past Issues > Articles online first > Journal of Neurosurgical Sciences 2021 Aug 03

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Journal of Neurosurgical Sciences 2021 Aug 03

DOI: 10.23736/S0390-5616.21.05389-3

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Are injectable regenerative therapies effective in the treatment of Degenerative Disc Disease? A systematic literature review

Alberto DI MARTINO , Francesca BARILE, Michele FIORE, Alberto RUFFILLI, Cesare FALDINI

First Orthopaedic and Traumatologic Clinic, Department of Biomedical and Neurimotor Science, IRCCS Istituto Ortopedico Rizzoli (IOR), University of Bologna, Bologna, Italy


PDF


INTRODUCTION: Degenerative disc disease is a major health concern in spine surgery. The aim of this article is to summarize the current knowledge about injectable regenerative therapies (Mesenchymal Stem Cells -MSC- or Platelet Rich Plasma - PRP) in degenerative disc disease.
EVIDENCE ACQUISITION: A research and analysis of the literature on Pubmed, Medscape, MEDLINE, Google Scholar and Cochrane databases was performed, in accordance with the Preferential Reporting Items for - Systematic Reviews and Meta-analyses (PRISMA) flowchart. Only peer-reviewed randomized controlled trials (RCTs), prospective single-arm trials, case series, and cohort studies were included.
EVIDENCE SYNTHESIS: A total of 17 studies were included. All were homogeneous regarding indications to the procedure: discogenic low-back pain for at least 3-6 months, failure of conservative treatment, MRI evidence of disc degeneration. A total of 182 patients were treated with MSC and 198 patients were treated with PRP. Considering the efficacy, the studies were heterogeneous in clinical evaluation systems; however, they all reported significant improvement in clinical and functional scores. Neither major complications nor adverse effects were reported by any author. As for radiographical outcome none of the studies reported a disc height improvement after treatment.
CONCLUSIONS: Degenerative disc disease is a major health concern. Regenerative therapies could play a role in the treatment of its symptoms, as they have been proven to be clinically effective, cheap, and safe. Nevertheless, further studies are needed, in order to establish evidence based standardized treatments.


KEY WORDS: Degenerative disc disease; Mesenchymal stem cells; Platelet rich plasma; Injectable regenerative therapies; Spine surgery

top of page